The Role :
This role is an exciting opportunity to be a critical part of Moderna’s Country Medical Affairs team. The Country Medical Advisor will be accountable for delivering the Moderna Medical Affairs strategy related to Moderna’s licensed vaccines and candidate vaccines still in development.
Initially, the role will be focused on supporting the continued roll-out of the COVID-19 vaccine. Longer term, this individual will help execute the Country Medical Affairs strategy for the Moderna Infectious Disease franchise.
To fulfill these objectives, the person in this role will partner and work closely with numerous external and internal stakeholders across Moderna, as well as regional and global colleagues within Medical Affairs and Research and Development.
S / He will contribute to developing the excellence and scientific leadership of Moderna’s Medical Affairs organization.
S / he will be responsible for proactive and continuous assessment of the dynamics of the external and internal environment and implement strategic plans to establish and evolve local Medical Affairs teams and ways of working based on this assessment.
Here’s What You’ll Do :
Execution and delivery of regional Medical Affairs plans for Infectious Disease (or each of the therapeutic areas), including tactical deliverables such as scientific exchange, support for clinical trials and real world evidence (when requested), post-licensure research, publication plans, investigator-initiated studies, and other knowledge transfer activities
Build and maintain a network of key scientific leaders in areas of relevance to the current and anticipated needs.
Develop and / or foster relationships with external stakeholders to ensure that robust local insights from healthcare practitioners and patients, enabling the generation of data that are needed to properly understand and value our innovative medicines and vaccines
Planning of effective medical education campaigns, scientific advisory boards, KOL engagements, webinars and presentations to develop an effective scientific engagement strategy for the country.
Participate in outcomes research / health economics engagements with national payers, Health Technology Assessment or regulatory agencies, in coordination with Real-World Evidence, Market Access and Commercial colleagues
Compliant management of compassionate use requests, pre-licensure patient access programs, patient access / support programs and similar activities
Here’s What You’ll Bring to the Table :
MD, PhD, or Public Health Diploma from a recognized institution, preferably with completion of an accredited residency program.
Additional advanced degrees and a current license to practice are a strong plus
Some experience in global pharmaceutical industry in Clinical Development and / or Medical Affairs with demonstrated successful track record
Experience in vaccines is strongly preferred
Strong understanding of the compliance environment in which Medical Affairs functions
Demonstrated effective organizational skills, including ability to set goals and align priorities
Excellent written and oral communication skills.
Strong willingness to collaborate with other functions, leveraging his / her network to pressure test own hypotheses and solutions.
Track record of navigating ambiguity by intuitively making connections and staying open to learning, experimenting, and growing accordingly.
Fluency in English, and ideally also in French. Conversational proficiency in French strongly preferred.
About Moderna :
In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed.
Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing.
Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most effective vaccines against the COVID-19 pandemic.
Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases.
Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit
Moderna is a smoke-free, alcohol-free and drug-free work environment.